These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35171673)

  • 1. Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia.
    Hu B; Li B; Li K; Liu Y; Li C; Zheng L; Zhang M; Yang T; Guo S; Dong X; Zhang T; Liu Q; Hussain A; Weng Y; Peng L; Zhao Y; Liang XJ; Huang Y
    Sci Adv; 2022 Feb; 8(7):eabm1418. PubMed ID: 35171673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
    Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
    J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-destabilizing ionizable lipid empowered imaging-guided siRNA delivery and cancer treatment.
    Guo S; Li K; Hu B; Li C; Zhang M; Hussain A; Wang X; Cheng Q; Yang F; Ge K; Zhang J; Chang J; Liang XJ; Weng Y; Huang Y
    Exploration (Beijing); 2021 Aug; 1(1):35-49. PubMed ID: 37366466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid.
    Suzuki Y; Ishihara H
    Int J Pharm; 2016 Aug; 510(1):350-8. PubMed ID: 27374199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs.
    Kauffman KJ; Dorkin JR; Yang JH; Heartlein MW; DeRosa F; Mir FF; Fenton OS; Anderson DG
    Nano Lett; 2015 Nov; 15(11):7300-6. PubMed ID: 26469188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the role of helper lipids in lipid nanoparticle formulations of siRNA.
    Kulkarni JA; Witzigmann D; Leung J; Tam YYC; Cullis PR
    Nanoscale; 2019 Nov; 11(45):21733-21739. PubMed ID: 31713568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a potent ionizable lipid for efficient macrophage transfection and systemic anti-interleukin-1β siRNA delivery against acute liver failure.
    Ding F; Zhang H; Li Q; Yang C
    J Mater Chem B; 2021 Jul; 9(25):5136-5149. PubMed ID: 34132324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells.
    Hu X; Jia X; Xu C; Wei Y; Wang Z; Liu G; You Q; Lu G; Gong W
    Metabolism; 2021 Jul; 120():154800. PubMed ID: 34051224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide/Lipid-Associated Nucleic Acids (PLANAs) as a Multicomponent siRNA Delivery System.
    Hall R; Alasmari A; Mozaffari S; Mahdipoor P; Parang K; Montazeri Aliabadi H
    Mol Pharm; 2021 Mar; 18(3):986-1002. PubMed ID: 33496597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B.
    Huang Y; Zheng S; Guo Z; de Mollerat du Jeu X; Liang XJ; Yang Z; Zhang HY; Gao S; Liang Z
    Signal Transduct Target Ther; 2022 Feb; 7(1):38. PubMed ID: 35145057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery.
    Whitehead KA; Sahay G; Li GZ; Love KT; Alabi CA; Ma M; Zurenko C; Querbes W; Langer RS; Anderson DG
    Mol Ther; 2011 Sep; 19(9):1688-94. PubMed ID: 21750531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable lipid nanoparticles induce a prolonged RNA interference-mediated protein knockdown and show rapid hepatic clearance in mice and nonhuman primates.
    Suzuki Y; Hyodo K; Suzuki T; Tanaka Y; Kikuchi H; Ishihara H
    Int J Pharm; 2017 Mar; 519(1-2):34-43. PubMed ID: 28089936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered ionizable lipid nanoparticles mediated efficient siRNA delivery to macrophages for anti-inflammatory treatment of acute liver injury.
    Zhang H; Ding F; Zhu Z; Sun Q; Yang C
    Int J Pharm; 2023 Jan; 631():122489. PubMed ID: 36521639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
    Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
    Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Delivery of RNAi by Reducible Interfering Nanoparticles (iNOPs).
    Baigude H; Su J; McCarroll J; Rana TM
    ACS Med Chem Lett; 2013 Aug; 4(8):720-723. PubMed ID: 24319542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.
    Akoumianakis I; Zvintzou E; Kypreos K; Filippatos TD
    Curr Atheroscler Rep; 2021 Mar; 23(5):20. PubMed ID: 33694000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexing the Pre-assembled Brush-like siRNA with Poly(β-amino ester) for Efficient Gene Silencing.
    Liu X; Ding F; Guo Y; Jiang K; Fu Y; Zhu L; Li M; Zhu X; Zhang C
    ACS Appl Bio Mater; 2022 May; 5(5):1857-1867. PubMed ID: 35107256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.